Portfolio Design Labs, LLC
Source: SEC Form 13F · as of Mar 2026Portfolio Design Labs, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $37.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$37.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 8,783 | $8.1M |
| JNJJOHNSON & JOHNSON | 27,205 | $6.6M |
| PMPhilip Morris International Inc | 22,988 | $3.8M |
| ABBVAbbVie Inc. | 11,086 | $2.4M |
| MCKMcKesson Corporation | 2,462 | $2.1M |
| ABTABBOTT LABORATORIES | 19,404 | $2.0M |
| MRKMerck & Co., Inc. | 15,936 | $1.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 7,037 | $1.9M |
| GILDGILEAD SCIENCES, INC. | 9,837 | $1.4M |
| PFEPFIZER INC | 46,721 | $1.3M |
| GMOptec International, Inc. | 17,002 | $1.3M |
| CORCencora Inc. | 3,515 | $1.1M |
| AMGNAMGEN INC | 3,078 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 12,242 | $742K |
| CAHCardinal Health Inc. | 2,896 | $612K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,191 | $532K |
| AZNASTRAZENECA PLC | 1,220 | $241K |
| DGXQuest Diagnostics Incorporated | 1,216 | $238K |
| NVSNovartis AG | 1,531 | $234K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.